Stitz
Jennifer Stitz, Cape Girardeau, MO US
Patent application number | Description | Published |
---|---|---|
20120325834 | DISPOSABLE PIZZA-BLOTTING COMPOSITE AND BOX ASSEMBLY INCLUDING SUCH COMPOSITE - A pizza-blotting composite includes an absorbent layer and a non-absorbent layer, the absorbent layer having an oleophilic surface and the non-absorbent layer having an oleophobic surface. The absorbent layer is low-linting and physiologically safe for food contact applications, such as removing oil from pizza. The absorbent layer and the non-absorbent layer are joined to form a composite, which is dimensioned to cover a substantial portion of a pizza's surface. A pizza box assembly is also provided with the pizza-blotting composite, in which the non-absorbent layer of the composite is secured to the interior of the top of the pizza box. | 12-27-2012 |
Jennifer D. Stitz, North Hollywood, CA US
Patent application number | Description | Published |
---|---|---|
20130015084 | DISPOSABLE PIZZA-BLOTTING COMPOSITE AND BOX ASSEMBLY - A food blotting composite includes an absorbent layer and a non-absorbent layer, the absorbent layer in one embodiment having an oleophilic surface and the non-absorbent layer having an oleophobic surface. The absorbent layer is physiologically safe for food contact applications, such as removing oil and grease from pizza and other cooked foods. A pizza box assembly and a blotting method also involve the pizza-blotting composite. In one embodiment the composite is positioned beneath the pizza with the absorbent layer facing upwardly to contact the underside of the pizza in use. | 01-17-2013 |
Jorn Stitz, Basel CH
Patent application number | Description | Published |
---|---|---|
20120021491 | IDENTIFICATION OF ANTIGEN OR LIGAND-SPECIFIC BINDING PROTEINS - The present invention discloses novel methods for the generation, expression and screening of diverse collections of binding proteins such as antibodies or fragments thereof in vertebrate host cells in vitro, for the identification and isolation of ligand- or antigen-specific binding proteins. The methods disclosed herein allow the expression of diverse collections of binding proteins from at least one vector construct, which optionally can give rise to collections of diverse binding proteins upon transfer and expression into vertebrate host cells in situ. | 01-26-2012 |
20150072412 | IDENTIFICATION OF ANTIGEN OR LIGAND-SPECIFIC BINDING PROTEINS - The present invention discloses novel methods for the generation, expression and screening of diverse collections of binding proteins such as antibodies or fragments thereof in vertebrate host cells in vitro, for the identification and isolation of ligand- or antigen-specific binding proteins. The methods disclosed herein allow the expression of diverse collections of binding proteins from at least one vector construct, which optionally can give rise to collections of diverse binding proteins upon transfer and expression into vertebrate host cells in situ. | 03-12-2015 |
Jörn Stitz, Basel CH
Patent application number | Description | Published |
---|---|---|
20120258494 | Retroviral Vector Particles and Methods for their Generation and Use - The present invention relates to methods of host cell transduction utilising ecotropic retroviral vector particles. The retroviral vector particle may comprise an envelope of Friend murine leukaemia virus, in particular the envelope encoded by molecular clone PVC-211 and the host cell may be engineered to recombinantly express the Reel receptor. The retroviral vector particles and methods of the invention can be used to introduce expressible polynucleotide sequences of interest into host cells with high efficiency. This results in protein production methods with higher yield (mg/L) and a reduction in manufacturing costs that could be used in a range of applications including for example, the production of therapeutic proteins, vaccines and antibodies. | 10-11-2012 |
Lothar Stitz, Kiebingen DE
Patent application number | Description | Published |
---|---|---|
20110098448 | ANTI-PRION PROTEIN ANTIBODY FRAGMENT - The invention relates to an antibody, antibody fragment or derivative thereof which specifically recognizes a prion protein and which comprises a complementarity determining region (CDR), a retro-inverso D-peptide of said CDR and/or an anti-idiotypic antibody, antibody fragment or derivative thereof which recognizes said CDR. The invention further concerns a nucleic acid molecule encoding said antibody, antibody fragment or derivative thereof as well as a method for generating an antibody, antibody fragment or derivative thereof that specifically recognizes a prion protein, wherein an antibody that recognizes a specific domain of the prion protein is generated, an antigen-specific amino acid sequence is isolated from said antibody, and an anti-idiotypic antibody, antibody fragment or derivative thereof, which recognizes said antigen-specific amino acid sequence, is generated. | 04-28-2011 |
Lothar Stitz, Rottenburg DE
Patent application number | Description | Published |
---|---|---|
20130295043 | VACCINATION IN ELDERLY PATIENTS - The present invention relates to vaccines comprising at least one mRNA encoding at least one antigen for use in the treatment of a disease in an elderly patient preferably exhibiting an age of at least 50 years, more preferably of at least 55 years, 60 years, 65 years, 70 years, or older, wherein the treatment comprises vaccination of the patient and eliciting an immune response in said patient. The present invention is furthermore directed to kits and kits of parts comprising such a vaccine and/or its components and to methods applying such a vaccine or kit. | 11-07-2013 |
20130336998 | VACCINATION IN NEWBORNS AND INFANTS - The present invention relates to vaccines comprising at least one mRNA encoding at least one antigen for use in the treatment of a disease in newborns and/or infants, preferably exhibiting an age of not more than 2 years, preferably of not more than 1 year, more preferably of not more than 9 months or even 6 months, wherein the treatment comprises vaccination of the newborn or infant and eliciting an immune response in said newborn or infant. The present invention is furthermore directed to kits and kits of parts comprising such a vaccine and/or its components and to methods applying such a vaccine or kit. | 12-19-2013 |
Matthias Stitz, Lohr Am Main DE
Patent application number | Description | Published |
---|---|---|
20090002109 | POLE TUBE AND ACTUATION MAGNET HAVING SUCH A POLE TUBE - A pole tube including a non-magnetic spacer ring configured to join a pole piece along a control cone and also configured to join a tube piece along a back annular surface. The annular surface includes a first face section and a second face section. The first face section and the second face section are disposed at an angle with respect to each other. | 01-01-2009 |
20120025938 | Electromagnet - An electromagnet having a pole tube, and having a coil that encompasses the pole tube and is mounted so as to be displaceable along a longitudinal axis of the pole tube, a first end face of the coil or of the housing thereof bearing on a first counter-bearing disposed at a first end portion of the pole tube, and an elastic element, which is supported on a second counter-bearing and biases the coil and/or the housing thereof against the first counter-bearing, is provided between a second end face of the coil or the housing thereof and the second counter-bearing disposed at a second end portion of the pole tube. | 02-02-2012 |